Plaque Modification Devices Market By Product Type (Atherectomy Devices (Rotational Atherectomy Devices, Directional Atherectomy Devices, Orbital Atherectomy Devices, Laser Atherectomy Devices), Thrombectomy Devices, Specialty Catheters, Others); By Application (Coronary Artery Disease (CAD), Peripheral Artery Disease (PAD)); By End-User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2032.

The global plaque modification devices market was USD 1.1 billion in 2023 and is expected to reach USD 1.9 billion by 2030, growing at a CAGR of 7.4%. The market growth is due to increasing incidence of cardiovascular diseases, increased proportion of older people, and improved technology.

 

The global Plaque Modification Devices market entails the use of tools aimed at treating the formation of arterial plague, the major requirement to efficient atherosclerosis and cardiovascular diseases treatments. These devices are employed in interventional cardiology and PAD, with the capability of deposing on dissolving or changing the plaques that hinder blood flow to eliminate flow obstructions that can cause complications such as strokes or attacks. The major product categories are atherectomy devices, thrombectomy devices, and specialty catheters.

 

Plaque Modification Devices Market: Aging Population Fueling Market Expansion

Increasing Prevalence of Cardiovascular Diseases (CVDs): One of the primary factors leading to the rising popularity of plaque modification devices is the increasing incidence of cardiovascular diseases, especially atherosclerosis, globally. The risk status of modern populations includes increased rates of high-fat diets, smoking, and reduced physical activity levels—all of which play a role in CVD occurrence. Epidemiological data by the WHO shows that CVD worldwide is responsible for 17.9 million deaths per year and claims 31% of global mortality.

 

Technological Advancements in Plaque Removal Devices: Advancements in atherectomy products and technologies have included laser atherectomy, orbital atherectomy, and directional atherectomy devices. They make the procedure more effective and safe thus improving the use of the advancements in the removal of the plaque. In 2023, the JetStream Atherectomy System was launched by Boston Scientific and is characterized by improved rotation for the ablation of plaque.

 

Growing Geriatric Population: A growing global and aging population is more susceptible to arterial diseases such as atherosclerosis, hence the need to use devices for plaque modification. According to statistics, in 2030, there will be 1.4 billion people above 65 years of age, thus increasing the market for these gadgets.

 

Plaque Modification Devices Market: Emerging Economies and Untapped Regional Potential

Expansion in Emerging Markets: Growth opportunities in emerging economies of Asia-Pacific and Latin American countries remain unexplored in the market. The growth of investment in the healthcare sector, coupled with the increasing incidences of awareness about cardiovascular diseases and the availability of better medical technologies, are expected to fuel the demand for these products in these regions. The Asia-Pacific market is projected to have the highest growth rate of approximately 8.5 % per year during the forecast period.

 

Integration of Artificial Intelligence (AI) and Robotics: The application of AI and robotics in plaque modification procedures offers chances to attain better accuracy, instant imaging, and predictive studies. In 2023, Philips introduced interventional cardiology based on artificial intelligence technology that helps in imaging while conducting plaque removal surgery.

 

Plaque Modification Devices Market: High Costs and Limited Accessibility Hindering Growth

High Costs of Procedures and Devices: The inherent high costs of plaque modification devices, as well as the procedures associated with such devices, are a major concern regarding their implementation, especially in areas of low economic activity. The average cost of a plaque modification procedure is $10,000-$25,000, depending on the type of device used and the healthcare center.

 

Stringent Regulatory Approvals: Long approval times and regulatory hurdles for modifying and creating new plaque modification devices can be problematic for companies entering the field. In 2023, the FDA tightened the requirements further for the PMD. Thus, the approval process took longer.

 

Plaque Modification Devices Market Segmentation

By Product Type

• Atherectomy Devices

  • Rotational Atherectomy Devices

  • Directional Atherectomy Devices

  • Orbital Atherectomy Devices

  • Laser Atherectomy Devices

• Thrombectomy Devices

• Specialty Catheters

• Others

 

By Application

• Coronary Artery Disease (CAD)

• Peripheral Artery Disease (PAD)

 

By End-User

• Hospitals

• Ambulatory Surgical Centers

• Specialty Clinics

 

By Region

• North America

• Europe

• Asia-Pacific

• Latin America

• Middle East & Africa

 

Segment Analysis

By Product Type

Atherectomy devices had the major share of the market in 2023, with a revenue share of 60%. These devices are used widely because they can more precisely emplace calcified and fibrotic plaques. Directional atherectomy devices are particularly useful in treating calcified lesions, which results in low restenosis rates.

 

Larger thrombectomy devices are projected to expand at a predictable rate due to growing usage in treating acute coronary syndromes and deep vein thrombosis.

 

By Application

The coronary artery disease (CAD) segment holds the largest market share due to the increased number of CAD patients around the world. CAD is responsible for 49% of deaths due to cardiovascular diseases, thereby underlining the importance of safe and efficient plaque removal tools.

 

The peripheral artery disease segment is also experiencing a similar trend and has shown a rise in procedural volume across both mature and developing nations.

 

Plaque Modification Devices Market: North America Leading with Advanced Healthcare Systems

North America dominated the market with 40% of the revenue share in 2023, due to the increased rate of cardiovascular disorders, effective healthcare systems, and increased handlers' adoption of sophisticated devices. The total overall market revenue in North America from these procedures is led by the US at around 70%, mainly due to a high procedural volume for both CAD and PAD interventions. The FDA later approved another generation of rotational atherectomy systems in 2023, improving the handling of calcified lesions.

 

Europe happens to be the second largest market primarily because of rising healthcare spending, rising incidences of chronic diseases, and growing adoption of minimally invasive procedures. Germany and the UK are key markets, as the demand for more sophisticated atherectomy systems and thrombectomy devices remains high. High awareness and stringers performed in Europe alone contributed to 30% of global vascular procedures in 2023.

 

The Asia-Pacific region is expected to be the highest growing, with a CAGR of 8.2% over the forecasting period. The major driving forces include fast urbanization, growing healthcare expenditure, and growing cardiovascular disease awareness. Example: As for the intervention related to PAD, the major three countries are China and Japan, contributing to the maximum and growing at a rate of at least 25 percent annually. Asia-Pacific captured 25% of the global market revenue in 2023 due to the increasing healthcare markets.

 

Plaque Modification Devices Market: Innovations and Strategies of Industry Leaders

• Boston Scientific Corporation

• Medtronic plc

• Abbott Laboratories

• Philips Healthcare

• Cardinal Health, Inc.

• Avinger, Inc.

• Terumo Corporation

• Biotronik SE & Co. KG

 

Strategies:

Product Innovation: Specialisation to improve the desired image acquisition and the correspondence of minimally invasive devices.

 

Geographical Expansion: Sustaining and extending strategic distribution channels in unexplored markets of the various worldwide regions.

 

Collaborations: Working with medical professionals and educational institutions on the main clinical trials and traineeship projects.

 

Future Outlook

The market for plaque modification devices is predicted to grow steadily due to social, technological, and geographical factors such as the rise in technology, the growing incidence of cardiovascular diseases, and improvement in the healthcare infrastructure in developing nations. New future technologies will encompass bioresorbable technologies, artificial intelligence, and real-time imaging assistance to optimize procedures and results.

 

Eventually, by the year 2030, smart devices will be commonplace with imaging and data analysis in cardiovascular care will be commonplace in the market. New entrants based on reasonable price and product differentiation will be critical to the market environment.

 

In conclusion, the plaque modification devices market belongs to the constantly developing markets, which have almost endless opportunities for expansion. Key buyers investing in research, regional expansion, and awareness programs are in a good position to reap benefits from this important market.